Page last updated: 2024-11-03

prazosin and Wallerian Degeneration

prazosin has been researched along with Wallerian Degeneration in 1 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Wallerian Degeneration: Degeneration of distal aspects of a nerve axon following injury to the cell body or proximal portion of the axon. The process is characterized by fragmentation of the axon and its MYELIN SHEATH.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Romeo, HE1
Spinedi, E1
Esquifino, AI1
Estivariz, F1
Cardinali, DP1

Other Studies

1 other study available for prazosin and Wallerian Degeneration

ArticleYear
Anterograde nerve degeneration after superior cervical ganglionectomy coexists with a decrease in arginine vasopressin release in rats.
    Neuroendocrinology, 1991, Volume: 54, Issue:4

    Topics: Animals; Arginine Vasopressin; Ganglia, Sympathetic; Ganglionectomy; Male; Nerve Fibers; Pituitary G

1991